FTO and neoplasm: Thus, aberrant expression or function of enzymes involved in the m6A modification process, including the methyltransferases FTO, METTL3, and METTL14, and the readers YTHDF1, YTHDF2, and YTHDC, has been reported to regulate malignant progression, immune infiltration, and chemotherapy resistance through m6A‐mediated mechanisms in various tumours.16